Azurion 7 B20
Payments companies reported to CMS as associated with Azurion 7 B20. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Azurion 7 B20, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Azurion 7 B20
These are the largest totals companies reported as associated with Azurion 7 B20. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Tareq Kass-Hout | Chicago, IL | Vascular Neurology | $18,879.37 |
| Guilherme Dabus | Miami, FL | Neuroradiology | $2,115.00 |
| Donny Baek | Los Angeles, CA | Vascular & Interventional Radiology | $1,610.47 |
| George So | Torrance, CA | Diagnostic Radiology | $1,325.79 |
| Paula Eboli | Torrance, CA | Neurological Surgery | $1,318.80 |
| Samir Patel | Panama City, FL | Interventional Cardiology | $766.67 |
| Aaron Hayson | Tallahassee, FL | Vascular Surgery | $758.65 |
| Bradley Bohnstedt | Indianapolis, IN | Neurological Surgery | $677.23 |
| Richard Jung | Bay Shore, NY | Vascular Neurology | $649.03 |
| John Spooner | Nashville, TN | Neurological Surgery | $515.55 |
Prescribed Azurion 7 B20?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.